Annotation Detail

Information
Associated Genes
IL1A
Associated Variants
NLRP3 p.Val198Met (p.V198M) ( ENST00000348069.7, ENST00000643234.2, ENST00000366496.7, ENST00000336119.8, ENST00000697350.1, ENST00000391827.3, ENST00000474792.2, ENST00000391828.8, ENST00000697408.2 )
NLRP3 p.Val198Leu (p.V198L) ( ENST00000336119.8, ENST00000697350.1, ENST00000366496.7, ENST00000348069.7, ENST00000643234.2, ENST00000697408.2, ENST00000391827.3, ENST00000474792.2, ENST00000391828.8 )
NLRP3 p.Val198Met (p.V198M) ( ENST00000336119.8, ENST00000348069.7, ENST00000366496.7, ENST00000391827.3, ENST00000391828.8, ENST00000474792.2, ENST00000643234.2, ENST00000697350.1, ENST00000697408.2 )
NLRP3 p.Val198Leu (p.V198L) ( ENST00000336119.8, ENST00000348069.7, ENST00000366496.7, ENST00000391827.3, ENST00000391828.8, ENST00000474792.2, ENST00000643234.2, ENST00000697350.1, ENST00000697408.2 )
Associated Disease
Inflammatory disorder
Source Database
DisGeNET
Description
We reviewed the clinical features of 3 members of a family, all of whom had MWS associated with the NALP3 variant V200M (also designated V198M), and evaluated the response of their inflammatory disease to treatment with the recombinant human IL-1 receptor antagonist anakinra.
Pubmed
14872505
Original source reporting the Gene Disease association
BeFree
DisGENET score for the Gene Disease association
0.00190009310456212
Year of publication
2004
Drugs